12-YEAR INCIDENCE OF CORONARY HEART-DISEASE IN MIDDLE-AGED ADULTS DURING THE ERA OF HYPERTENSIVE THERAPY - THE FRAMINGHAM OFFSPRING STUDY

被引:64
作者
WILSON, PWF [1 ]
ANDERSON, KM [1 ]
CASTELLI, WP [1 ]
机构
[1] BOSTON UNIV, SCH MED, EVANS MED GRP, BOSTON, MA 02118 USA
关键词
D O I
10.1016/0002-9343(91)90500-W
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: To provide information on the incidence of coronary heart disease (CHD) in the offspring of the original cohort from the Framingham Heart Study. PATIENTS AND METHODS: From 1972 to 1974, offspring of the original participants in the Framingham Heart Study underwent a baseline examination for standard cardiovascular risk factors. At entry into the study, these offspring were 30 to 59 years old and free of CHD. They were followed for 12 years, during which time 156 of 1,663 men and 55 of 1,714 women developed CHD. RESULTS: In a multivariate proportional hazards model, CHD was significantly associated with age, lower high-density lipoprotein cholesterol (HDL-C) levels, and number of cigarettes smoked. Fasting glucose levels and low-density lipoprotein cholesterol (LDL-C) were highly associated with CHD in men, but borderline in women, while triglycerides and very-low-density lipoprotein cholesterol were not significantly associated with CHD after adjustment for HDL-C and glucose. Blood pressure medication was used in half of the hypertensive individuals, and systolic pressure was associated with CHD in women only. CONCLUSIONS: This study confirms the importance of the common CHD risk factors of cigarette smoking and LDL-C, and extends the prognostic role of HDL-C in a middle-aged cohort. The impact of blood pressure, with or without use of hypertensive medications, was reduced in this study, and the data suggest that this attenuation was due to successful treatment.
引用
收藏
页码:11 / 16
页数:6
相关论文
共 28 条
  • [1] HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, TOTAL CHOLESTEROL SCREENING, AND MYOCARDIAL-INFARCTION - THE FRAMINGHAM-STUDY
    ABBOTT, RD
    WILSON, PWF
    KANNEL, WB
    CASTELLI, WP
    [J]. ARTERIOSCLEROSIS, 1988, 8 (03): : 207 - 211
  • [2] JOINT DISTRIBUTION OF LIPOPROTEIN CHOLESTEROL CLASSES - THE FRAMINGHAM-STUDY
    ABBOTT, RD
    GARRISON, RJ
    WILSON, PWF
    EPSTEIN, FH
    CASTELLI, WP
    FEINLEIB, M
    LARUE, C
    [J]. ARTERIOSCLEROSIS, 1983, 3 (03): : 260 - 272
  • [3] ABELL LL, 1952, J BIOL CHEM, V195, P357
  • [4] [Anonymous], 1988, ARCH INTERN MED, V148, P1023
  • [5] INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY
    CASTELLI, WP
    GARRISON, RJ
    WILSON, PWF
    ABBOTT, RD
    KALOUSDIAN, S
    KANNEL, WB
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20): : 2835 - 2838
  • [6] COX DR, 1972, J R STAT SOC B, V48, P133
  • [7] PROGRESS IN THE BATTLE AGAINST HYPERTENSION - CHANGES IN BLOOD-PRESSURE LEVELS IN THE UNITED-STATES FROM 1960 TO 1980
    DANNENBERG, AL
    DRIZD, T
    HORAN, MJ
    HAYNES, SG
    LEAVERTON, PE
    [J]. HYPERTENSION, 1987, 10 (02) : 226 - 233
  • [8] ENGER SC, 1979, ARTERY, V5, P170
  • [9] HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE
    FRICK, MH
    ELO, O
    HAAPA, K
    HEINONEN, OP
    HEINSALMI, P
    HELO, P
    HUTTUNEN, JK
    KAITANIEMI, P
    KOSKINEN, P
    MANNINEN, V
    MAENPAA, H
    MALKONEN, M
    MANTTARI, M
    NOROLA, S
    PASTERNACK, A
    PIKKARAINEN, J
    ROMO, M
    SJOBLOM, T
    NIKKILA, EA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) : 1237 - 1245
  • [10] TOTAL AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN THE SERUM AND RISK OF MORTALITY - EVIDENCE OF A THRESHOLD EFFECT
    GOLDBOURT, U
    HOLTZMAN, E
    NEUFELD, HN
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1985, 290 (6477): : 1239 - 1243